BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7565632)

  • 1. Effects of gamma-glutamyl hydrolase on folyl and antifolylpolyglutamates in cultured H35 hepatoma cells.
    Yao R; Rhee MS; Galivan J
    Mol Pharmacol; 1995 Sep; 48(3):505-11. PubMed ID: 7565632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquisition of resistance to antifolates caused by enhanced gamma-glutamyl hydrolase activity.
    Rhee MS; Wang Y; Nair MG; Galivan J
    Cancer Res; 1993 May; 53(10 Suppl):2227-30. PubMed ID: 7683570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of folylpolyglutamate synthetase and gamma-glutamyl hydrolase in altering cellular folyl- and antifolylpolyglutamates.
    Galivan J; Johnson T; Rhee M; McGuire JJ; Priest D; Kesevan V
    Adv Enzyme Regul; 1987; 26():147-55. PubMed ID: 3499766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretion of gamma-glutamyl hydrolase in vitro.
    O'Connor BM; Rotundo RF; Nimec Z; McGuire JJ; Galivan J
    Cancer Res; 1991 Aug; 51(15):3874-81. PubMed ID: 1713122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of folylpolyglutamate synthetase in the regulation of methotrexate polyglutamate formation in H35 hepatoma cells.
    Johnson TB; Nair MG; Galivan J
    Cancer Res; 1988 May; 48(9):2426-31. PubMed ID: 2451560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamyl hydrolase: properties and pharmacologic impact.
    Galivan J; Ryan T; Rhee M; Yao R; Chave K
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):33-7. PubMed ID: 10598552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamyl hydrolase and the multitargeted antifolate LY231514.
    Rhee MS; Ryan TJ; Galivan J
    Cancer Chemother Pharmacol; 1999; 44(5):427-32. PubMed ID: 10501918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple mechanisms of resistance to polyglutamatable and lipophilic antifolates in mammalian cells: role of increased folylpolyglutamylation, expanded folate pools, and intralysosomal drug sequestration.
    Jansen G; Barr H; Kathmann I; Bunni MA; Priest DG; Noordhuis P; Peters GJ; Assaraf YG
    Mol Pharmacol; 1999 Apr; 55(4):761-9. PubMed ID: 10101035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-dependent suppression in glutamyl hydrolase activity and elevated cellular methotrexate polyglutamates.
    Galivan J; Rhee MS
    Biochem Pharmacol; 1995 Nov; 50(10):1659-63. PubMed ID: 7503769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrolytic cleavage of methotrexate gamma-polyglutamates by folylpolyglutamyl hydrolase derived from various tumors and normal tissues of the mouse.
    Samuels LL; Goutas LJ; Priest DG; Piper JR; Sirotnak FM
    Cancer Res; 1986 May; 46(5):2230-5. PubMed ID: 2421872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutamyl hydrolase. pharmacological role and enzymatic characterization.
    Galivan J; Ryan TJ; Chave K; Rhee M; Yao R; Yin D
    Pharmacol Ther; 2000 Mar; 85(3):207-15. PubMed ID: 10739875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma-glutamyl hydrolase and drug resistance.
    Schneider E; Ryan TJ
    Clin Chim Acta; 2006 Dec; 374(1-2):25-32. PubMed ID: 16859665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of 5-fluorodeoxyuridine and quinazoline antifolates on murine leukemia self-cultured in vitro.
    Balińska M; Szablewska I; Janiszewska D; Brzezińska A; Pawełczak K
    Acta Biochim Pol; 1997; 44(4):735-42. PubMed ID: 9584853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism-based inhibitors of folylpoly-gamma-glutamate synthetase and gamma-glutamyl hydrolase: control of folylpoly-gamma-glutamate homeostasis as a drug target.
    Coward JK; McGuire JJ
    Vitam Horm; 2008; 79():347-73. PubMed ID: 18804701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determinants of activity of the antifolate thymidylate synthase inhibitors Tomudex (ZD1694) and GW1843U89 against mono- and multilayered colon cancer cell lines under folate-restricted conditions.
    Peters GJ; Smitskamp-Wilms E; Smid K; Pinedo HM; Jansen G
    Cancer Res; 1999 Nov; 59(21):5529-35. PubMed ID: 10554030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multifactorial resistance to 5,10-dideazatetrahydrofolic acid in cell lines derived from human lymphoblastic leukemia CCRF-CEM.
    Pizzorno G; Moroson BA; Cashmore AR; Russello O; Mayer JR; Galivan J; Bunni MA; Priest DG; Beardsley GP
    Cancer Res; 1995 Feb; 55(3):566-73. PubMed ID: 7834626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The properties of the secreted gamma-glutamyl hydrolases from H35 hepatoma cells.
    Wang Y; Nimec Z; Ryan TJ; Dias JA; Galivan J
    Biochim Biophys Acta; 1993 Aug; 1164(3):227-35. PubMed ID: 8343522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New methods for the study of folate coenzymes: endogenous polyglutamate patterns of subcellular hepatocyte fractions and of regenerating rat liver.
    Krumdieck CL; Eto I; Krumdieck R
    Adv Exp Med Biol; 1983; 163():115-37. PubMed ID: 6613724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate polyglutamate and monoglutamate accumulation in normal and SV40-transformed human fibroblasts.
    Hoffman RM; Coalson DW; Jacobsen SJ; Erbe RW
    J Cell Physiol; 1981 Dec; 109(3):497-505. PubMed ID: 6274882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate analogues. 33. Synthesis of folate and antifolate poly-gamma-glutamates by [(9-fluorenylmethoxy)oxy]carbonyl chemistry and biological evaluation of certain methotrexate polyglutamate polylysine conjugates as inhibitors of the growth of H35 hepatoma cells.
    Abraham A; Nair MG; Kisliuk RL; Gaumont Y; Galivan J
    J Med Chem; 1990 Feb; 33(2):711-7. PubMed ID: 1688946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.